BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 23428859)

  • 1. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
    Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
    Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.
    Cao J; Dong Y; Mao F; Wang W
    Biomed Res Int; 2018; 2018():6469703. PubMed ID: 30225261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 3D-CEUS in the Recurrence of Liver Cancer after Radiofrequency Ablation.
    Bai L; Wang X; Shi S; Gao J; Li X; Wang Y; Jiang M; Zheng C; Liu H
    J Healthc Eng; 2021; 2021():3123553. PubMed ID: 34966520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review.
    Jeong WK
    J Liver Cancer; 2023 Sep; 23(2):272-283. PubMed ID: 37723641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology.
    Jeong WK; Kang HJ; Choi SH; Park MS; Yu MH; Kim B; You MW; Lim S; Cho YS; Lee MW; Hwang JA; Lee JY; Kim JH; Joo I; Bae JS; Kim SY; Chung YE; Kim DH; Lee JM
    Korean J Radiol; 2023 Jun; 24(6):482-497. PubMed ID: 37271203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study.
    Ruan SM; Cheng MQ; Huang H; Hu HT; Li W; Xie XY; Lu MD; Kuang M; Lin MX; Wang W
    J Hepatocell Carcinoma; 2022; 9():437-451. PubMed ID: 35620274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective assessment of diagnostic efficacy and safety of Sonazoid
    Lv K; Zhai H; Jiang Y; Liang P; Xu HX; Du L; Chou YH; Xie X; Luo Y; Lee YJ; Lee JY; Hu B; Luo B; Wang Y; Luan Y; Kalli C; Chen K; Wang W; Liang JD
    Abdom Radiol (NY); 2021 Oct; 46(10):4647-4659. PubMed ID: 34136936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
    Lee JY; Minami Y; Choi BI; Lee WJ; Chou YH; Jeong WK; Park MS; Kudo N; Lee MW; Kamata K; Iijima H; Kim SY; Numata K; Sugimoto K; Maruyama H; Sumino Y; Ogawa C; Kitano M; Joo I; Arita J; Liang JD; Lin HM; Nolsoe C; Gilja OH; Kudo M
    J Med Ultrasound; 2020; 28(2):59-82. PubMed ID: 32874864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
    Lee JY; Minami Y; Choi BI; Lee WJ; Chou YH; Jeong WK; Park MS; Kudo N; Lee MW; Kamata K; Iijima H; Kim SY; Numata K; Sugimoto K; Maruyama H; Sumino Y; Ogawa C; Kitano M; Joo I; Arita J; Liang JD; Lin HM; Nolsoe C; Gilja OH; Kudo M
    Ultrasonography; 2020 Jul; 39(3):191-220. PubMed ID: 32447876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Iwamoto T; Okabe J; Takamura M; Fujita N; Hori M; Takehara T; Kudo M; Murakami T
    Liver Cancer; 2016 Oct; 5(4):269-279. PubMed ID: 27781199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta-analysis.
    Shi W; He Y; Ding W; Gong S; Wang Y; Xiao J; He B
    Br J Radiol; 2016 Aug; 89(1064):20150973. PubMed ID: 27327401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma.
    Kudo M
    Liver Cancer; 2016 Feb; 5(1):1-7. PubMed ID: 26989655
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
    Chen BB; Murakami T; Shih TT; Sakamoto M; Matsui O; Choi BI; Kim MJ; Lee JM; Yang RJ; Zeng MS; Chen RC; Liang JD
    Liver Cancer; 2015 Dec; 4(4):215-27. PubMed ID: 26734577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI.
    Minami Y; Kudo M
    Liver Cancer; 2015 Mar; 4(2):106-14. PubMed ID: 26697413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.
    Maruyama H; Sekimoto T; Yokosuka O
    J Gastroenterol; 2016 May; 51(5):421-33. PubMed ID: 26694825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Teng W; Liu KW; Lin CC; Jeng WJ; Chen WT; Sheen IS; Lin CY; Lin SM
    Liver Cancer; 2015 Mar; 4(1):26-38. PubMed ID: 26020027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced ultrasonography: advance and current status in abdominal imaging.
    Chung YE; Kim KW
    Ultrasonography; 2015 Jan; 34(1):3-18. PubMed ID: 25342120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic-pathologic correlation of three-dimensional shear-wave elastographic findings in assessing the liver ablation volume after radiofrequency ablation.
    Sugimoto K; Oshiro H; Ogawa S; Honjo M; Hara T; Moriyasu F
    World J Gastroenterol; 2014 Sep; 20(33):11850-5. PubMed ID: 25206291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.
    Minami Y; Nishida N; Kudo M
    World J Gastroenterol; 2014 Apr; 20(15):4160-6. PubMed ID: 24764654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.
    Zheng SG; Xu HX; Liu LN
    World J Radiol; 2014 Jan; 6(1):7-14. PubMed ID: 24578787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.